Showing results (101-110 of 193) with videos related to
Sort By:
Pageof 20
BMJ (Clinical Research Ed.)|November 22, 2005
Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational studyPatricia Cane, Ian Chrystie, David Dunn, et al.AIDS (London, England)|March 14, 2020
Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIVXinzhu Wang, Marta Boffito, Laura Dickinson, et al.AIDS (London, England)|December 30, 2025
Associations between plasma biomarkers and changes in cognitive function over two years in people with and without HIVJasmini Alagaratnam, Nicholas Bakewell, Ken M Kunisaki, et al.AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.AIDS (London, England)|April 21, 2026
Temporal trends in viral SetPoint and peak CD4 cell count soon after HIV-1 seroconversionNikos Pantazis, Caroline Sabin, Dominique Costagliola, et al.The Journal of Infectious Diseases|January 24, 2025
Associations Between the Gut Microbiome, Inflammation, and Cardiovascular Profiles in People With Human Immunodeficiency VirusRachel MacCann, Junhui Li, Alejandro Abner Garcia Leon, et al.Journal of the International AIDS Society|November 14, 2014
Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D studyCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.International Journal of STD & AIDS|April 14, 2025
Post-acute sequelae of COVID-19 in people of Black ethnicities living with HIV in the United KingdomZoe Ottaway, Lucy Campbell, Julie Fox, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 29, 2020
HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European citiesGordana Avramovic, Maeve Reilly, Walter Cullen, et al.European Journal of Preventive Cardiology|April 18, 2015
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis-Møller, Lene Ryom, Colette Smith, et al.Pageof 20